The prevalence of obesity and metabolic abnormalities in eastern China: a cross-sectional study

  • Jie Fan
  • Hui Hua Li
  • Xing Zhen LiuEmail author
  • Shan HuangEmail author
Original Article



Populations in different countries and regions have different characteristics of cardiovascular risk factors. Grasping these characteristics and developing targeted prevention and management strategies are essential to prevent cardiovascular diseases (CVD). So we conducted this study to investigate the prevalence of overweight/obesity and metabolic abnormalities of adults in eastern China.


We collected data of 103,183 adults who received routine physical examination. Compared the prevalence of overweight/obesity, metabolic indicators, and the proportion of metabolic abnormalities in different age and gender subgroups.


Compared with other age and gender subgroups, middle-aged male had a significantly higher prevalence of general and abdominal overweight/obesity (48.8%/15.1% and 43%/13.3%, respectively). In addition, the prevalence of high DBP, hyperuricemia, high TC, TG, LDL, Non-HDLc, and low HDL-C were 24.6%, 15.8%, 34.5%, 45.1%, 19.4%, 23.6%, and 36.7%, respectively in midlife male.


Middle-aged male had higher level of CVD risk in eastern China. Government, individuals, and health care professionals should develop targeted age and gender-based intervention to prevent weight gain and manage metabolic abnormalities.


Obesity Cardiovascular disease Risk factors 


Compliance with ethical standards

Ethical approval

Ethical approval was obtained from the ethics review boards of the Hangzhou Aeronautical Sanatorium of Chinese Air Force.

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.CrossRefGoogle Scholar
  2. 2.
    NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387(10026):1377–96.CrossRefGoogle Scholar
  3. 3.
    NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–42.CrossRefGoogle Scholar
  4. 4.
    Emerging Risk Factors Collaboration, Wormser D, Kaptoge S, Di Angelantonio E, Wood AM, Pennells L, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011;377(9771):1085–95.CrossRefGoogle Scholar
  5. 5.
    Kollia N, Panagiotakos DB, Georgousopoulou E, Chrysohoou C, Tousoulis D, Stefanadis C, et al. Exploring the association between low socioeconomic status and cardiovascular disease risk in healthy Greeks, in the years of financial crisis (2002–2012): the ATTICA study. Int J Cardiol. 2016;223:758–63.CrossRefPubMedGoogle Scholar
  6. 6.
    Kershaw KN, Osypuk TL, Do DP, De Chavez PJ, Diez Roux AV. Neighborhood-level racial/ethnic residential segregation and incident cardiovascular disease: the multi-ethnic study of atherosclerosis. Circulation. 2015;131(2):141–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Schultz WM, Kelli HM, Lisko JC, Varghese T, Shen J, Sandesara P, et al. Socioeconomic status and cardiovascular outcomes: challenges and interventions. Circulation. 2018;137(20):2166–78.CrossRefPubMedGoogle Scholar
  8. 8.
    Andrieieva A, Babak O, Pluzhnykova O. Influence of visfatin and endotelial nitric oxide synthase on the functional state of the vascular wall in hypertensive patients with abdominal obesity. Atherosclerosis. 2017;263:e127.CrossRefGoogle Scholar
  9. 9.
    Fan J, Xu JH, Wang J, Wang GZ, Zhang YQ, Liu XZ. Effects of laparoscopic adjustable gastric banding on weight loss, metabolism, and obesity-related comorbidities: 5-year results in China. Obes Surg. 2014;24(6):891–6.CrossRefPubMedGoogle Scholar
  10. 10.
    Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72.CrossRefPubMedGoogle Scholar
  11. 11.
    WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–63.CrossRefGoogle Scholar
  12. 12.
    American Diabetes Association. Standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S144–51.CrossRefGoogle Scholar
  13. 13.
    Liu XZ, Gao Y, Fan J, Xu X, Zhang J, Gao J, et al. Metabolic abnormalities in rheumatoid arthritis patients with comorbid diabetes mellitus. Clin Rheumatol. 2018;37(1):219–26.CrossRefPubMedGoogle Scholar
  14. 14.
    Zhou J, Wang Y, Lian F, Chen D, Qiu Q, Xu H, et al. Physical exercises and weight loss in obese patients help to improve uric acid. Oncotarget. 2017;8(55):94893–9.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Johansson HE, Wåhlén A, Aldenbäck E, Haenni A. Platelet Counts counts and liver enzymes after gastric bypass surgery. Obes Surg. 2017;28(6):1526–31.CrossRefPubMedCentralGoogle Scholar
  16. 16.
    Li H, Yan X, Deng X, Yang L, Zhao S, Zou J, et al. Magnitude of and gender differences in cardiovascular risk profiles among community residents in Shenzhen. China Public Health. 2017;147:59–65.CrossRefPubMedGoogle Scholar
  17. 17.
    Yu D, Shi J, Zhang H, Wang Z, Lu Y, Zhang B, et al. Identifying patterns of non-communicable diseases in developed eastern coastal China: a longitudinal study of electronic health records from 12 public hospitals. BMJ Open. 2017;7(10):e016007.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Qasim A, Turcotte M, de Souza RJ, Samaan MC, Champredon D, Dushoff J, et al. On the origin of obesity: identifying the biological, environmental and cultural drivers of genetic risk among human populations. Obes Rev. 2018;19(2):121–49.CrossRefPubMedGoogle Scholar
  19. 19.
    Siljee JE, Wang Y, Bernard AA, Ersoy BA, Zhang S, Marley A, et al. Subcellular localization of MC4R with ADCY3 at neuronal primary cilia underlies a common pathway for genetic predisposition to obesity. Nat Genet. 2018;50(2):180–5.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Goodarzi MO. Genetics of obesity: what genetic association studies have taught us about the biology of obesity and its complications. Lancet Diabetes Endocrinol. 2018;6(3):223–36.CrossRefPubMedGoogle Scholar
  21. 21.
    O’Brien EC, Alberdi G, McAuliffe FM. The influence of socioeconomic status on gestational weight gain: a systematic review. J Public Health (Oxf). 2018;40(1):41–55.CrossRefGoogle Scholar
  22. 22.
    Weihrauch-Blüher S, Richter M, Staege MS. Body weight regulation, socioeconomic status and epigenetic alterations. Metabolism. 2018;85:109–15.CrossRefPubMedGoogle Scholar
  23. 23.
    Kivimäki M, Kawachi I. Work stress as a risk factor for cardiovascular disease. Curr Cardiol Rep. 2015;17(9):630.CrossRefPubMedGoogle Scholar
  24. 24.
    Safar ME. Arterial stiffness as a risk factor for clinical hypertension. Nat Rev Cardiol. 2018;15(2):97–105.CrossRefPubMedGoogle Scholar
  25. 25.
    Lim K, Jackson KL, Sata Y, Head GA. Factors responsible for obesity-related hypertension. Curr Hypertens Rep. 2017;19(7):53.CrossRefPubMedGoogle Scholar
  26. 26.
    Kivimäki M, Steptoe A. Effects of stress on the development and progression of cardiovascular disease. Nat Rev Cardiol. 2018;15(4):215–29.CrossRefPubMedGoogle Scholar
  27. 27.
    Liu XZ, Li HH, Huang S, Zhao DB. Association between hyperuricemia and nontraditional adiposity indices. Clin Rheumatol. 2018.
  28. 28.
    King C, Lanaspa MA, Jensen T, Tolan DR, Sánchez-Lozada LG, Johnson RJ. Uric acid as a cause of the metabolic syndrome. Contrib Nephrol. 2018;192:88–102.CrossRefPubMedGoogle Scholar
  29. 29.
    Pomeranz JL, Mozaffarian D, Micha R. Can the government require health warnings on sugar-sweetened beverage advertisements? JAMA. 2018;319(3):227–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Yan S, Shen X, Liang L, Yang L, Zhang Y, Liao M, et al. Evaluation of three BMI criteria performance to diagnose obesity in a Chinese population. Int J Diabetes Dev Ctries. 2016;36(2):158–66.CrossRefGoogle Scholar

Copyright information

© Research Society for Study of Diabetes in India 2019

Authors and Affiliations

  1. 1.Zhejiang Police CollegeHangzhouChina
  2. 2.Departmemt of Endocrinology, Tongren HospitalShanghai Jiao Tong University School of MedicineShanghaiChina
  3. 3.Army Convalescence AreaHangzhou Aeronautical Sanatorium of Chinese Air ForceHangzhouChina

Personalised recommendations